{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:36:34Z","timestamp":1790807794867,"version":"4.1.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Investigating the impact of circadian syndrome (CircS) on the prognosis of non-muscle-invasive bladder cancer (NMIBC), identifying potential indicators affecting prognosis, and explaining NMIBC prognosis from the perspective of circadian rhythm disruption to provide a preventable risk factor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>A total of 438 patients with NMIBC who received intravesical Bacillus Calmette-Gu\u00e9rin immunotherapy after transurethral resection of bladder tumor were selected for retrospective analysis by retrieving medical records. The primary outcomes were recurrence-free survival (RFS) and progression-free survival (PFS). The secondary endpoints were safety parameters. Least absolute shrinkage and selection operator (LASSO) regression was used to screen variables for COX regression. Subgroup analysis and sensitivity analyses were used to validate the robustness of the results. Bootstrap and K-fold cross-validations were used to validate the robustness of the models. All adverse events (AEs) were further quantified for association strength using a logistic regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      This retrospective study screened 406 patients who met the inclusion criteria for further analysis. Survival analysis demonstrated significantly lower RFS in patients with CircS compared to the non-CircS cohort [Log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.018; hazard ratio (HR)\u00a0=\u00a01.58, 95% confidence interval (CI): 1.08\u20132.31]. Multivariable analysis of LASSO-selected variables identified CircS (HR\u00a0=\u00a01.72, 95% CI: 1.09\u20132.73,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.021), male gender (HR\u00a0=\u00a02.04, 95% CI: 1.12\u20133.72,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.02), recurrence history (HR\u00a0=\u00a01.79, 95% CI: 1.17\u20132.73,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.007), and tumor diameter &gt;3 cm (HR\u00a0=\u00a01.88, 95% CI: 1.24\u20132.87,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.003) as independent predictors of inferior RFS in NMIBC. Notably, elevated serum albumin levels exhibited protective effects (HR\u00a0=\u00a00.91, 95% CI: 0.85\u20130.98,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.008). The prognostic significance of CircS remained robust across multiple RFS validation models, though no significant association was observed with PFS. In the analysis of AEs, patients with CircS showed significantly higher odds, such as lower urinary tract symptoms (OR\u00a0=\u00a01.64, 95% CI: 1.02\u20132.63,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.041), hematuria (OR\u00a0=\u00a02.94, 95% CI: 1.55\u20135.50,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), dysuria (OR\u00a0=\u00a04.26, 95% CI: 1.67\u201311.08,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.002), lower abdominal pain (OR\u00a0=\u00a04.28, 95% CI: 1.59\u201311.73,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.004), fatigue (OR\u00a0=\u00a03.86, 95% CI: 1.60\u20139.34,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.002), and arthralgia or flu-like symptoms (OR\u00a0=\u00a07.30, 95% CI: 1.40\u201353.31,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.023).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CircS may serve as a potential risk factor affecting the prognosis of NMIBC, manifesting as worse RFS and AEs. Along with gender, tumor size, and recurrence history, it constitutes a high-risk factor for RFS. This finding provides clues for exploring potential causal relationships between clinical syndromes caused by circadian rhythm disruption and bladder tumor prognosis, while also reshaping the understanding of connections between chronic non-neoplastic diseases and neoplastic diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003740","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:00:30Z","timestamp":1762272030000},"page":"3948-3961","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The prognostic value of circadian syndrome in non-muscle-invasive bladder cancer: a retrospective cohort study"],"prefix":"10.1097","volume":"112","author":[{"given":"Jun-Wei","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Urology, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Institute of Urology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jiang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Urology, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Institute of Urology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Jin","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Urology, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Institute of Urology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Urology, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Institute of Urology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"101235","DOI":"10.1016\/j.plipres.2023.101235","article-title":"Lipid metabolism around the body clocks","volume":"91","author":"Petrenko","year":"2023","journal-title":"Prog Lipid Res"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41392-022-00899-y","article-title":"Molecular regulations of circadian rhythm and implications for physiology and diseases","volume":"7","author":"Fagiani","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"7\u201324","DOI":"10.1038\/s41582-021-00577-7","article-title":"Circadian rhythms in neurodegenerative disorders","volume":"18","author":"Nassan","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"287\u2013307","DOI":"10.1038\/s41573-020-00109-w","article-title":"Circadian rhythm as a therapeutic target","volume":"20","author":"Ruan","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"R5-20260512","first-page":"181\u201391","article-title":"The circadian syndrome: is the metabolic syndrome and much more!","volume":"286","author":"Zimmet","year":"2019","journal-title":"J Intern Med"},{"key":"R6-20260512","first-page":"851\u201360","article-title":"The circadian syndrome predicts cardiovascular disease better than metabolic syndrome in Chinese adults","volume":"289","author":"Shi","year":"2021","journal-title":"J Intern Med"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"23\u201328","DOI":"10.1016\/j.puhe.2024.10.002","article-title":"Association of circadian syndrome with risk of hyperuricemia among middle-aged and older adults in China: the first nationwide cohort study","volume":"238","author":"Wang","year":"2025","journal-title":"Public Health"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"100089","DOI":"10.1016\/j.tjpad.2025.100089","article-title":"The interaction between circadian syndrome and genetic susceptibility in the risk of incident dementia: a longitudinal cohort study","volume":"12","author":"Yu","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1186\/s12889-023-15934-y","article-title":"Association between circadian syndrome and the prevalence of kidney stones in overweight adults: a cross-sectional analysis of NHANES 2007-2018","volume":"23","author":"Xiao","year":"2023","journal-title":"BMC Public Health"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"1137191","DOI":"10.3389\/fpubh.2023.1137191","article-title":"A positive association between the prevalence of circadian syndrome and overactive bladder in United States adults","volume":"11","author":"Xiao","year":"2023","journal-title":"Front Public Health"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"715830","DOI":"10.3389\/fmed.2021.715830","article-title":"The circadian syndrome predicts lower urinary tract symptoms suggestive of benign prostatic hyperplasia better than metabolic syndrome in aging males: a 4-year follow-up study","volume":"8","author":"Xiong","year":"2021","journal-title":"Front Med Lausanne"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"2796\u2013810","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"597\u2013614","DOI":"10.1038\/s41585-023-00773-8","article-title":"Urine biomarkers in bladder cancer - current status and future perspectives","volume":"20","author":"Maas","year":"2023","journal-title":"Nat Rev Urol"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"731\u201339","DOI":"10.1038\/s41574-020-00427-4","article-title":"Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer","volume":"16","author":"Bishehsari","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"e170998","DOI":"10.1172\/JCI170998","article-title":"Circadian disruption, clock genes, and metabolic health","volume":"134","author":"Schrader","year":"2024","journal-title":"J Clin Invest"},{"key":"R16-20260512","first-page":"100081","article-title":"Revised Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"87\u201397","DOI":"10.1016\/j.comppsych.2017.04.001","article-title":"The development and validation of huaxi emotional-distress index (HEI): a Chinese questionnaire for screening depression and anxiety in non-psychiatric clinical settings","volume":"76","author":"Wang","year":"2017","journal-title":"Compr Psychiatry"},{"key":"R18-20260512","first-page":"245\u201371","article-title":"American cancer society guideline for diet and physical activity for cancer prevention","volume":"70","author":"Rock","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12876-024-03504-4","article-title":"Association between circadian syndrome and gallstones in US adult: a cross-sectional study of NHANES 2017-2020","volume":"24","author":"Liang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"469\u201380","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2013a new world-wide definition. A consensus statement from the international diabetes federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"5437\u201347","DOI":"10.1200\/JCO.23.00307","article-title":"Definitions, end points, and clinical trial designs for bladder cancer: recommendations from the society for immunotherapy of cancer and the international bladder cancer group","volume":"41","author":"Kamat","year":"2023","journal-title":"J Clin Oncol"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"70\u201379","DOI":"10.1016\/j.clnu.2025.03.016","article-title":"A comprehensive comparison of two commonly used BMI thresholds for non-communicable diseases and multimorbidity in the Chinese population","volume":"48","author":"Fan","year":"2025","journal-title":"Clin Nutr"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"447\u201361","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"R24-20260512","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ejso.2021.04.011","article-title":"When to consider logistic LASSO regression in multivariate analysis?","volume":"47","author":"Hu","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"R25-20260512","doi-asserted-by":"crossref","first-page":"267\u201388","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"Journal of the Royal Statistical Society Series B, Statistical Methodology"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"75\u201394","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"e19802","DOI":"10.1016\/j.heliyon.2023.e19802","article-title":"The role of cancer-associated fibroblasts in bladder cancer progression","volume":"9","author":"Huang","year":"2023","journal-title":"Heliyon"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"1322\u201332","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp Mol Med"},{"key":"R30-20260512","first-page":"366\u201375","article-title":"Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities","volume":"6","author":"Caramelo","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"e2303230","DOI":"10.1002\/advs.202303230","article-title":"Cancer-associated fibroblast-induced remodeling of tumor microenvironment in recurrent bladder cancer","volume":"10","author":"Liang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"R32-20260512","first-page":"546\u201356","article-title":"Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis","volume":"5","author":"Wang","year":"2024","journal-title":"Nat Cancer"},{"key":"R33-20260512","first-page":"12312\u201334","article-title":"Identification of a circadian-based prognostic signature predicting cancer-associated fibroblasts infiltration and immunotherapy response in bladder cancer","volume":"16","author":"Zhou","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"R34-20260512","doi-asserted-by":"crossref","first-page":"453\u201369","DOI":"10.1038\/s41583-018-0026-z","article-title":"Generation of circadian rhythms in the suprachiasmatic nucleus","volume":"19","author":"Hastings","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"R35-20260512","doi-asserted-by":"crossref","first-page":"379\u201385","DOI":"10.1126\/science.1195262","article-title":"Temperature as a universal resetting cue for mammalian circadian oscillators","volume":"330","author":"Buhr","year":"2010","journal-title":"Science"},{"key":"R36-20260512","doi-asserted-by":"crossref","first-page":"2950\u201361","DOI":"10.1101\/gad.183500","article-title":"Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus","volume":"14","author":"Damiola","year":"2000","journal-title":"Genes Dev"},{"key":"R37-20260512","doi-asserted-by":"crossref","first-page":"994\u201399","DOI":"10.1126\/science.aah4965","article-title":"Circadian time signatures of fitness and disease","volume":"354","author":"Bass","year":"2016","journal-title":"Science"},{"key":"R38-20260512","doi-asserted-by":"crossref","first-page":"2133\u201341","DOI":"10.1172\/JCI46043","article-title":"Circadian rhythms, sleep, and metabolism","volume":"121","author":"Huang","year":"2011","journal-title":"J Clin Invest"},{"key":"R39-20260512","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-022-01238-y","article-title":"Circadian rhythms and cancers: the intrinsic links and therapeutic potentials","volume":"15","author":"Zhou","year":"2022","journal-title":"J Hematol Oncol"},{"key":"R40-20260512","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41398-020-0694-0","article-title":"Circadian rhythm disruption and mental health","volume":"10","author":"Walker","year":"2020","journal-title":"Transl Psychiatry"},{"key":"R41-20260512","doi-asserted-by":"crossref","first-page":"2195\u2013203","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus calmette-guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"R42-20260512","doi-asserted-by":"crossref","first-page":"466\u20135","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"R43-20260512","doi-asserted-by":"crossref","first-page":"759153","DOI":"10.3389\/fonc.2022.759153","article-title":"Impact of circadian rhythms on the development and clinical management of genitourinary cancers","volume":"12","author":"Kaur","year":"2022","journal-title":"Front Oncol"},{"key":"R44-20260512","doi-asserted-by":"crossref","first-page":"525\u201333","DOI":"10.1111\/imm.13747","article-title":"Circadian rhythm regulation in the immune system","volume":"171","author":"Ding","year":"2024","journal-title":"Immunology"},{"key":"R45-20260512","doi-asserted-by":"crossref","first-page":"48\u201359","DOI":"10.1111\/j.1749-6632.2009.05300.x","article-title":"Effects of sleep and circadian rhythm on the human immune system","volume":"1193","author":"Lange","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"R46-20260512","doi-asserted-by":"crossref","first-page":"475\u201394","DOI":"10.1016\/j.trecan.2019.07.002","article-title":"Interplay between circadian clock and cancer: new frontiers for cancer treatment","volume":"5","author":"Sulli","year":"2019","journal-title":"Trends Cancer"},{"key":"R47-20260512","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41420-024-01960-1","article-title":"Circadian rhythm regulates the function of immune cells and participates in the development of tumors","volume":"10","author":"Zeng","year":"2024","journal-title":"Cell Death Discov"},{"key":"R48-20260512","doi-asserted-by":"crossref","first-page":"1\u201310","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"R49-20260512","first-page":"25153\u201379","article-title":"A circadian rhythm-related gene signature associated with tumor immunity, cisplatin efficacy, and prognosis in bladder cancer","volume":"13","author":"Zhou","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R50-20260512","doi-asserted-by":"crossref","first-page":"122974","DOI":"10.1016\/j.lfs.2024.122974","article-title":"ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner","volume":"355","author":"Wang","year":"2024","journal-title":"Life Sci"},{"key":"R51-20260512","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/s12885-016-2580-y","article-title":"Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes","volume":"16","author":"Litlekalsoy","year":"2016","journal-title":"BMC Cancer"},{"key":"R52-20260512","doi-asserted-by":"crossref","first-page":"801\u201309","DOI":"10.1503\/cmaj.051351","article-title":"Health benefits of physical activity: the evidence","volume":"174","author":"Warburton","year":"2006","journal-title":"Cmaj"},{"key":"R53-20260512","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"R54-20260512","doi-asserted-by":"crossref","first-page":"887\u201394","DOI":"10.1016\/j.eururo.2013.08.009","article-title":"Mediterranean diet and prostate cancer risk and mortality in the health professionals follow-up study","volume":"65","author":"Kenfield","year":"2014","journal-title":"Eur Urol"},{"key":"R55-20260512","doi-asserted-by":"crossref","first-page":"12\u201317","DOI":"10.1016\/j.cca.2020.11.011","article-title":"The circadian clock and inflammation: a new insight","volume":"512","author":"Xu","year":"2021","journal-title":"Clin Chim Acta"},{"key":"R56-20260512","doi-asserted-by":"crossref","first-page":"528\u201335","DOI":"10.3109\/07420528.2011.580869","article-title":"Effect of shiftwork on systemic markers of inflammation","volume":"28","author":"Puttonen","year":"2011","journal-title":"Chronobiol Int"},{"key":"R57-20260512","doi-asserted-by":"crossref","first-page":"190\u201398","DOI":"10.1038\/nri3386","article-title":"Circadian control of the immune system","volume":"13","author":"Scheiermann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R58-20260512","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41419-020-02839-6","article-title":"ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF\/BETA pathway and is regulated by miR-26a-5p","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"R59-20260512","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41419-024-06860-x","article-title":"The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing AMOTL2-LATS-YAP pathway","volume":"15","author":"Zou","year":"2024","journal-title":"Cell Death Dis"},{"key":"R60-20260512","first-page":"254\u201358","article-title":"Circadian disruption and breast cancer: from melatonin to clock genes","volume":"16","author":"Stevens","year":"2005","journal-title":"Epidemiology"},{"key":"R61-20260512","first-page":"532\u201340","article-title":"Rotating night-shift work and the risk of breast cancer in the nurses","volume":"186","author":"Wegrzyn","year":"2017","journal-title":"Health Studies Am J Epidemiol"},{"key":"R62-20260512","doi-asserted-by":"crossref","first-page":"1241\u201346","DOI":"10.1093\/carcin\/bgi075","article-title":"Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers","volume":"26","author":"Chen","year":"2005","journal-title":"Carcinogenesis"},{"key":"R63-20260512","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1530\/ERC-15-0030","article-title":"Melatonin: an inhibitor of breast cancer","volume":"22","author":"Hill","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"R64-20260512","doi-asserted-by":"crossref","first-page":"e2214829120","DOI":"10.1073\/pnas.2214829120","article-title":"Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle","volume":"120","author":"Qu","year":"2023","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:15:18Z","timestamp":1778580918000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003740","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"2025-06-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}